The U.S. Food and Drug Administration (FDA) has approved the first flu vaccine built on messenger RNA (mRNA) technology, months after the agency refused to even consider the application. The shot, called mFLUSIVA, is made by Moderna and was cleared on Wednesday.
Approval covers adults ages 50...